Successful treatment of lipoprotein glomerulopathy in a daughter and a mother using niceritrol

Clinical and Experimental Nephrology

Volumn 14, Issue 6, 2010, Pages 619-624

  Hamatani, Hiroko ^a   Hiromura, Keiju ^b   Kobatake, Keiko ^a   Yoshida, Hiroaki ^a   Kobayashi, Satsuki ^a   Yoneda, Naohiro ^b   Kayakabe, Ken ^b   Matsumoto, Takayuki ^b   Kuroiwa, Takashi ^b   Ueki, Kazue ^a   Nojima, Yoshihisa ^b  

^a Dialysis and Rheumatology Center   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Apolipoprotein E; Lipoprotein glomerulopathy; Niceritrol; Proteinuria

Indexed keywords

APOLIPOPROTEIN E; CREATININE; CYCLOPHOSPHAMIDE; DIPYRIDAMOLE; ENALAPRIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID ETHYL ESTER; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICERITROL; PRAVASTATIN; TRIACYLGLYCEROL; WARFARIN;

ADOLESCENT; ADULT; APOLIPOPROTEIN E GENE; ARTICLE; CASE REPORT; CHILD; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GENE; GENE MUTATION; GLOMERULOPATHY; HEMATURIA; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; LEG EDEMA; LIPOPROTEIN GLOMERULOPATHY; PEDIGREE ANALYSIS; PRESCHOOL CHILD; PROTEINURIA; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; APOLIPOPROTEINS E; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; KIDNEY GLOMERULUS; MIDDLE AGED; MUTATION; NEPHROTIC SYNDROME; NICERITROL; PEDIGREE; PROTEINURIA;

EID: 78650961765     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0333-9     Document Type: Article

References (17)

1. T Saito H Sato K Kudo S Oikawa T Shibata Y Hara, et al. 1989 Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia Am J Kidney Dis 13 148 153 1:STN:280:DyaL1M7jt1GltQ%3D%3D 2644825
2. Y Watanabe I Ozaki F Yoshida A Fukatsu Y Itoh S Matsuo, et al. 1989 A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis Nephron 51 265 270 1:STN:280:DyaL1M7islOiug%3D%3D 10.1159/000185297 2644575
3. T Saito A Matsunaga S Oikawa 2006 Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases Am J Kidney Dis 47 199 211 1:CAS:528:DC%2BD28XhslWntrs%3D 10.1053/j.ajkd.2005.10.017 16431249 (Pubitemid 43121323)
4. N Ieiri O Hotta Y Taguma 2003 Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy Am J Kidney Dis 41 244 249 10.1053/ajkd.2003.50016 12500244 (Pubitemid 36043374)
5. T Arai S Yamashita M Yamane N Manabe T Matsuzaki K Kiriyama, et al. 2003 Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy Atherosclerosis 169 293 299 1:CAS:528:DC%2BD3sXmt1Gqurg%3D 10.1016/S0021-9150(03)00194-1 12921981 (Pubitemid 37297476)
6. M Kinomura H Sugiyama T Saito A Matsunaga KE Sada M Kanzaki, et al. 2008 A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy Nephrol Dial Transplant 23 751 756 1:CAS:528:DC%2BD1cXhvVemtLk%3D 10.1093/ndt/gfm675 18045818 (Pubitemid 351767634)
7. M Kibata M Ishida K Asano H Uehara K Saito T Fuchimoto, et al. 1980 Clinical study of niceritrol on serum lipids in the treatment of hyperlipidemia Atherosclerosis 37 333 342 1:STN:280:DyaL3M7gvFOqtw%3D%3D 10.1016/0021-9150(80) 90137-9 7458980 (Pubitemid 10025591)
8. A Owada S Suda T Hata 2003 Antiproteinuric effect of niceritrol, a nicotinic acid derivative, in chronic renal disease with hyperlipidemia: a randomized trial Am J Med 114 347 353 1:CAS:528:DC%2BD3sXjtVKht7o%3D 10.1016/S0002-9343(02)01567-X 12714122 (Pubitemid 36513681)
9. K Maruyama H Arai T Ogawa S Tomizawa A Morikawa 1997 Lipoprotein glomerulopathy: a pediatric case report Pediatr Nephrol 11 213 214 1:STN:280:DyaK2s3ks1SmtQ%3D%3D 10.1007/s004670050264 9090668 (Pubitemid 27122696)
10. T Ogawa K Maruyama H Hattori H Arai I Kondoh T Egashira, et al. 2000 A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy Pediatr Nephrol 14 149 151 1:STN:280:DC%2BD3c7kvVCisg%3D%3D 10.1007/ s004670050032 10684367
11. T Saito S Oikawa H Sato J Sasaki 1999 Lipoprotein glomerulopathy: renal lipidosis induced by novel apolipoprotein E variants Nephron 83 193 201 1:CAS:528:DyaK1MXntVansLs%3D 10.1159/000045511 10529625 (Pubitemid 29486397)
12. M Amenomori M Haneda J Morikawa I Nishigaki S Maeda H Hidaka, et al. 1994 A case of lipoprotein glomerulopathy successfully treated with probucol Nephron 67 109 113 1:STN:280:DyaK2czivFahsg%3D%3D 10.1159/000187897 8052351
13. A Matsunaga M Furuyama T Hashimoto K Toyoda D Ogino K Hayasaka 2009 Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy Clin Exp Nephrol 13 659 662 1:CAS:528:DC%2BC3cXhtFCiu74%3D 10.1007/s10157-009-0207-1 19603250
14. H Drexel 2009 Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients? Fundam Clin Pharmacol 23 687 692 1:CAS:528:DC%2BD1MXhsFWit7rN 10.1111/j.1472-8206.2009.00745.x 19682084
15. Y Lin SS Mousa N Elshourbagy SA Mousa 2010 Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy Vasc Health Risk Manag 6 73 85 1:CAS:528:DC%2BC3cXitlCjs7g%3D 20234782
16. AJ Taylor TC Villines EJ Stanek PJ Devine L Griffen M Miller, et al. 2009 Extended-release niacin or ezetimibe and carotid intima-media thickness N Engl J Med 361 2113 2122 1:CAS:528:DC%2BD1MXhsFSnsLzP 10.1056/NEJMoa0907569 19915217
17. Y Kanamaru A Nakao I Shirato K Okumura H Ogawa Y Tomino, et al. 2002 Chronic graft-versus-host autoimmune disease in Fc receptor gamma chain-deficient mice results in lipoprotein glomerulopathy J Am Soc Nephrol 13 1527 1533 1:CAS:528:DC%2BD38XkvFels7k%3D 10.1097/01.ASN.0000015615.14428.67 12039982 (Pubitemid 34579242)